Baidu
map

Cell:急性骨髓性白血病(AML)干细胞依赖昼夜节律环路的调控

2016-04-11 何嫱 生物通

一项新研究表明,昼夜节律环路对于急性骨髓性白血病干细胞(AML)而非健康血细胞至关重要,这为AML的治疗指出了可能的信号通路。 有一句俗话叫做“时间就是一切”。对于AML来说,这句格言可能是真的。在发表于4月7日《细胞》(Cell)杂志上的一篇论文中,由来自麻省理工学院与哈佛医学院Broad研究所、Brigham妇女医院(BWH)的研究人员领导的一个国际研究小组报告称,缺失它们的内部“钟表发

一项新研究表明,昼夜节律环路对于急性骨髓性白血病干细胞(AML)而非健康血细胞至关重要,这为AML的治疗指出了可能的信号通路。

有一句俗话叫做“时间就是一切”。对于AML来说,这句格言可能是真的。在发表于4月7日《细胞》(Cell)杂志上的一篇论文中,由来自麻省理工学院与哈佛医学院Broad研究所、Brigham妇女医院(BWH)的研究人员领导的一个国际研究小组报告称,缺失它们的内部“钟表发条”AML干细胞不能存活。

这些称作为昼夜节律的“发条”,充当了包括人类在内一些生物体的内部计时系统。昼夜节律可以根据大约24小时的日周期节律影响我们的睡眠/觉醒周期、代谢、激素生成和其他功能。这一周期的运转与环境条件如光线和温度相一致。

医学界很久以前就认识到了这些昼夜节律的存在。在过去的半个世纪,科学家们已经绘制出了一些维持这些发条运转的遗传回路。但还不清楚这一回路是否在每个细胞中都活化,或这种活性在癌细胞与健康细胞之间的差异程度。新研究发现昼夜节律回路在健康和癌性造血干细胞中均起作用。有意思地是,破坏这一回路(破坏“发条”的齿轮)会损害AML细胞的活力,而健康血细胞则未受损伤。

研究小组是在筛查白血病细胞生存必不可少的基因活性时获得这一研究发现的。

论文的资深作者、Broad研究所成员Benjamin Ebert,说:“Broad研究所Klarman细胞观测台的一项计划打算探究白血病干细胞的这一回路。我们与Broad研究所遗传干扰平台合作完成了一项遗传筛查,以鉴别出对AML干细胞旺盛生成必不可少的一组基因。”

令他们吃惊地是,在这些筛查中得分的两个基因是Clock和Bmal1——已知这些基因在一个复合物中协同作用调控了机体的昼夜节律。

论文的第一作者、Ebert实验室研究生Rishi Puram解释道:“在鉴别出Clock和Bmal1是我们遗传筛查的命中基因后,我们对此感兴趣的原因在于对于昼夜节律在白血病中的作用尚未有人进行过深入的研究。我们看到了一个发现某些新生物学的机会。”

在利用其他的方法(包括短发夹RNAs、CRISPR/Cas9和化学小分子)证实这些研究结果后,研究小组利用了一种只有血细胞内删除掉Bmal1 基因的“基因敲除”小鼠模型。该研究小组发现,尽管AML细胞需要Bmal1实现生长,正常造血干细胞在Bmal1不表达的条件下也可以存活。

“我们的研究表明,白血病细胞更依赖于昼夜节律回路:这两个基因表达对于白血病细胞的生存至关重要,而正常造血干细胞没有它也能存活。这正是我们在癌症生物学中寻找的——癌细胞与正常细胞的相对依赖性。这种依赖性可以成为一种治疗靶标,”Ebert说。

尽管研究人员强调还未确定是否可以利用这种依赖进行治疗,这些研究结果为未来的研究提供了诱人的可能性。

Puram说:“下一步是确定通过用一种药物直接扰乱这一信号通路,或通过在一天中AML细胞尤其易受伤害的时候按剂量给予化疗药物——这种方法叫做‘时间疗法’,来操控这一昼夜节律是否具有治疗作用。”时间疗法已在其他一些癌症类型,如胃肠癌和乳腺癌中显示出前景,但尚未证实对白血病有效。新研究结果提供了昼夜节律回路在AML中作用的一些重要见解,表明某一天时间疗法可作为AML或其他血癌患者一种有用的治疗方法。

Puram说:“鉴于我们的研究发现表明在AML中昼夜节律回路完好,白血病细胞中的这种基因表达在一天里周期性变化,这肯定值得去探索。我们是否能够利用它来实现治疗是我们一路向前有兴趣调查的一个问题。”

AML是一种骨髓性白细胞(而非淋巴性白细胞)异常增殖的血癌。其特点是骨髓内异常细胞的快速增殖而影响了正常血细胞的产生。AML是成年人最常见的急性白血病。

原始出处:

Puram RV, Kowalczyk MS, de Boer CG, Schneider RK, Miller PG, McConkey M, Tothova Z, Tejero H, Heckl D, Järås M, Chen MC, Li H, Tamayo A, Cowley GS, Rozenblatt-Rosen O, Al-Shahrour F, Regev A, Ebert BL. Core Circadian Clock Genes Regulate Leukemia Stem Cells in AML. Cell. 2016 Apr 7;165(2):303-316. doi: 10.1016/j.cell.2016.03.015.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (10)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1869334, encodeId=1a91186933410, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Mon May 02 04:00:00 CST 2016, time=2016-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85665, encodeId=af418566519, content=PDF文件:http://sci-hub.cc/10.1016/j.cell.2016.03.015, beContent=null, objectType=article, channel=null, level=null, likeNumber=205, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri May 13 17:57:00 CST 2016, time=2016-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85655, encodeId=9fec85655dc, content=请问 有人有PDF格式的吗 <br> , beContent=null, objectType=article, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/87BEB7C1C01469F4FC5BE4D730CCFC3E/100, createdBy=8ad91724127, createdName=sodabb8bb03c, createdTime=Fri May 13 15:23:00 CST 2016, time=2016-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1959591, encodeId=d12c195959159, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Fri May 06 04:00:00 CST 2016, time=2016-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78031, encodeId=fa5ce80310e, content=高大上的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:20:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78032, encodeId=8f50e803298, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:20:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77661, encodeId=6269e766118, content=夜间效果好吧?, beContent=null, objectType=article, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211004/21b1fa92cec74fb5b0b160bcc3a13716/3df82edb6cc74c2a9a5a9b5faef160f1.jpg, createdBy=40c81607191, createdName=shanganquan, createdTime=Wed Apr 13 13:16:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1424098, encodeId=5a8414240985f, content=<a href='/topic/show?id=4ece524e593' target=_blank style='color:#2F92EE;'>#急性骨髓性白血病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52475, encryptionId=4ece524e593, topicName=急性骨髓性白血病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07ce3903085, createdName=zxxiang, createdTime=Wed Apr 13 05:00:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1514393, encodeId=26d3151439335, content=<a href='/topic/show?id=1ae010211143' target=_blank style='color:#2F92EE;'>#髓性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102111, encryptionId=1ae010211143, topicName=髓性)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Apr 13 05:00:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77421, encodeId=71aee742155, content=学习了 长知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaEJJAFMgSjibMicGVUgkmDBw4svXiccQxZicwjRHNxGPTghAmITxP12Rcmm0yFKfwGwUaiaUwpPUUUTOd2g/0, createdBy=fcd21609070, createdName=hekzn, createdTime=Mon Apr 11 16:20:00 CST 2016, time=2016-04-11, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1869334, encodeId=1a91186933410, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Mon May 02 04:00:00 CST 2016, time=2016-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85665, encodeId=af418566519, content=PDF文件:http://sci-hub.cc/10.1016/j.cell.2016.03.015, beContent=null, objectType=article, channel=null, level=null, likeNumber=205, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri May 13 17:57:00 CST 2016, time=2016-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85655, encodeId=9fec85655dc, content=请问 有人有PDF格式的吗 <br> , beContent=null, objectType=article, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/87BEB7C1C01469F4FC5BE4D730CCFC3E/100, createdBy=8ad91724127, createdName=sodabb8bb03c, createdTime=Fri May 13 15:23:00 CST 2016, time=2016-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1959591, encodeId=d12c195959159, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Fri May 06 04:00:00 CST 2016, time=2016-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78031, encodeId=fa5ce80310e, content=高大上的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:20:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78032, encodeId=8f50e803298, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:20:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77661, encodeId=6269e766118, content=夜间效果好吧?, beContent=null, objectType=article, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211004/21b1fa92cec74fb5b0b160bcc3a13716/3df82edb6cc74c2a9a5a9b5faef160f1.jpg, createdBy=40c81607191, createdName=shanganquan, createdTime=Wed Apr 13 13:16:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1424098, encodeId=5a8414240985f, content=<a href='/topic/show?id=4ece524e593' target=_blank style='color:#2F92EE;'>#急性骨髓性白血病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52475, encryptionId=4ece524e593, topicName=急性骨髓性白血病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07ce3903085, createdName=zxxiang, createdTime=Wed Apr 13 05:00:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1514393, encodeId=26d3151439335, content=<a href='/topic/show?id=1ae010211143' target=_blank style='color:#2F92EE;'>#髓性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102111, encryptionId=1ae010211143, topicName=髓性)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Apr 13 05:00:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77421, encodeId=71aee742155, content=学习了 长知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaEJJAFMgSjibMicGVUgkmDBw4svXiccQxZicwjRHNxGPTghAmITxP12Rcmm0yFKfwGwUaiaUwpPUUUTOd2g/0, createdBy=fcd21609070, createdName=hekzn, createdTime=Mon Apr 11 16:20:00 CST 2016, time=2016-04-11, status=1, ipAttribution=)]
    2016-05-13 lovetcm

    PDF文件:http://sci-hub.cc/10.1016/j.cell.2016.03.015

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1869334, encodeId=1a91186933410, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Mon May 02 04:00:00 CST 2016, time=2016-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85665, encodeId=af418566519, content=PDF文件:http://sci-hub.cc/10.1016/j.cell.2016.03.015, beContent=null, objectType=article, channel=null, level=null, likeNumber=205, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri May 13 17:57:00 CST 2016, time=2016-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85655, encodeId=9fec85655dc, content=请问 有人有PDF格式的吗 <br> , beContent=null, objectType=article, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/87BEB7C1C01469F4FC5BE4D730CCFC3E/100, createdBy=8ad91724127, createdName=sodabb8bb03c, createdTime=Fri May 13 15:23:00 CST 2016, time=2016-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1959591, encodeId=d12c195959159, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Fri May 06 04:00:00 CST 2016, time=2016-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78031, encodeId=fa5ce80310e, content=高大上的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:20:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78032, encodeId=8f50e803298, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:20:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77661, encodeId=6269e766118, content=夜间效果好吧?, beContent=null, objectType=article, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211004/21b1fa92cec74fb5b0b160bcc3a13716/3df82edb6cc74c2a9a5a9b5faef160f1.jpg, createdBy=40c81607191, createdName=shanganquan, createdTime=Wed Apr 13 13:16:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1424098, encodeId=5a8414240985f, content=<a href='/topic/show?id=4ece524e593' target=_blank style='color:#2F92EE;'>#急性骨髓性白血病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52475, encryptionId=4ece524e593, topicName=急性骨髓性白血病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07ce3903085, createdName=zxxiang, createdTime=Wed Apr 13 05:00:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1514393, encodeId=26d3151439335, content=<a href='/topic/show?id=1ae010211143' target=_blank style='color:#2F92EE;'>#髓性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102111, encryptionId=1ae010211143, topicName=髓性)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Apr 13 05:00:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77421, encodeId=71aee742155, content=学习了 长知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaEJJAFMgSjibMicGVUgkmDBw4svXiccQxZicwjRHNxGPTghAmITxP12Rcmm0yFKfwGwUaiaUwpPUUUTOd2g/0, createdBy=fcd21609070, createdName=hekzn, createdTime=Mon Apr 11 16:20:00 CST 2016, time=2016-04-11, status=1, ipAttribution=)]
    2016-05-13 sodabb8bb03c

    请问 有人有PDF格式的吗

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1869334, encodeId=1a91186933410, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Mon May 02 04:00:00 CST 2016, time=2016-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85665, encodeId=af418566519, content=PDF文件:http://sci-hub.cc/10.1016/j.cell.2016.03.015, beContent=null, objectType=article, channel=null, level=null, likeNumber=205, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri May 13 17:57:00 CST 2016, time=2016-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85655, encodeId=9fec85655dc, content=请问 有人有PDF格式的吗 <br> , beContent=null, objectType=article, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/87BEB7C1C01469F4FC5BE4D730CCFC3E/100, createdBy=8ad91724127, createdName=sodabb8bb03c, createdTime=Fri May 13 15:23:00 CST 2016, time=2016-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1959591, encodeId=d12c195959159, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Fri May 06 04:00:00 CST 2016, time=2016-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78031, encodeId=fa5ce80310e, content=高大上的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:20:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78032, encodeId=8f50e803298, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:20:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77661, encodeId=6269e766118, content=夜间效果好吧?, beContent=null, objectType=article, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211004/21b1fa92cec74fb5b0b160bcc3a13716/3df82edb6cc74c2a9a5a9b5faef160f1.jpg, createdBy=40c81607191, createdName=shanganquan, createdTime=Wed Apr 13 13:16:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1424098, encodeId=5a8414240985f, content=<a href='/topic/show?id=4ece524e593' target=_blank style='color:#2F92EE;'>#急性骨髓性白血病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52475, encryptionId=4ece524e593, topicName=急性骨髓性白血病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07ce3903085, createdName=zxxiang, createdTime=Wed Apr 13 05:00:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1514393, encodeId=26d3151439335, content=<a href='/topic/show?id=1ae010211143' target=_blank style='color:#2F92EE;'>#髓性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102111, encryptionId=1ae010211143, topicName=髓性)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Apr 13 05:00:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77421, encodeId=71aee742155, content=学习了 长知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaEJJAFMgSjibMicGVUgkmDBw4svXiccQxZicwjRHNxGPTghAmITxP12Rcmm0yFKfwGwUaiaUwpPUUUTOd2g/0, createdBy=fcd21609070, createdName=hekzn, createdTime=Mon Apr 11 16:20:00 CST 2016, time=2016-04-11, status=1, ipAttribution=)]
    2016-05-06 维他命
  5. [GetPortalCommentsPageByObjectIdResponse(id=1869334, encodeId=1a91186933410, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Mon May 02 04:00:00 CST 2016, time=2016-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85665, encodeId=af418566519, content=PDF文件:http://sci-hub.cc/10.1016/j.cell.2016.03.015, beContent=null, objectType=article, channel=null, level=null, likeNumber=205, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri May 13 17:57:00 CST 2016, time=2016-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85655, encodeId=9fec85655dc, content=请问 有人有PDF格式的吗 <br> , beContent=null, objectType=article, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/87BEB7C1C01469F4FC5BE4D730CCFC3E/100, createdBy=8ad91724127, createdName=sodabb8bb03c, createdTime=Fri May 13 15:23:00 CST 2016, time=2016-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1959591, encodeId=d12c195959159, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Fri May 06 04:00:00 CST 2016, time=2016-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78031, encodeId=fa5ce80310e, content=高大上的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:20:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78032, encodeId=8f50e803298, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:20:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77661, encodeId=6269e766118, content=夜间效果好吧?, beContent=null, objectType=article, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211004/21b1fa92cec74fb5b0b160bcc3a13716/3df82edb6cc74c2a9a5a9b5faef160f1.jpg, createdBy=40c81607191, createdName=shanganquan, createdTime=Wed Apr 13 13:16:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1424098, encodeId=5a8414240985f, content=<a href='/topic/show?id=4ece524e593' target=_blank style='color:#2F92EE;'>#急性骨髓性白血病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52475, encryptionId=4ece524e593, topicName=急性骨髓性白血病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07ce3903085, createdName=zxxiang, createdTime=Wed Apr 13 05:00:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1514393, encodeId=26d3151439335, content=<a href='/topic/show?id=1ae010211143' target=_blank style='color:#2F92EE;'>#髓性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102111, encryptionId=1ae010211143, topicName=髓性)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Apr 13 05:00:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77421, encodeId=71aee742155, content=学习了 长知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaEJJAFMgSjibMicGVUgkmDBw4svXiccQxZicwjRHNxGPTghAmITxP12Rcmm0yFKfwGwUaiaUwpPUUUTOd2g/0, createdBy=fcd21609070, createdName=hekzn, createdTime=Mon Apr 11 16:20:00 CST 2016, time=2016-04-11, status=1, ipAttribution=)]
    2016-04-14 李继凯

    高大上的文章

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1869334, encodeId=1a91186933410, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Mon May 02 04:00:00 CST 2016, time=2016-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85665, encodeId=af418566519, content=PDF文件:http://sci-hub.cc/10.1016/j.cell.2016.03.015, beContent=null, objectType=article, channel=null, level=null, likeNumber=205, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri May 13 17:57:00 CST 2016, time=2016-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85655, encodeId=9fec85655dc, content=请问 有人有PDF格式的吗 <br> , beContent=null, objectType=article, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/87BEB7C1C01469F4FC5BE4D730CCFC3E/100, createdBy=8ad91724127, createdName=sodabb8bb03c, createdTime=Fri May 13 15:23:00 CST 2016, time=2016-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1959591, encodeId=d12c195959159, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Fri May 06 04:00:00 CST 2016, time=2016-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78031, encodeId=fa5ce80310e, content=高大上的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:20:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78032, encodeId=8f50e803298, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:20:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77661, encodeId=6269e766118, content=夜间效果好吧?, beContent=null, objectType=article, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211004/21b1fa92cec74fb5b0b160bcc3a13716/3df82edb6cc74c2a9a5a9b5faef160f1.jpg, createdBy=40c81607191, createdName=shanganquan, createdTime=Wed Apr 13 13:16:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1424098, encodeId=5a8414240985f, content=<a href='/topic/show?id=4ece524e593' target=_blank style='color:#2F92EE;'>#急性骨髓性白血病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52475, encryptionId=4ece524e593, topicName=急性骨髓性白血病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07ce3903085, createdName=zxxiang, createdTime=Wed Apr 13 05:00:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1514393, encodeId=26d3151439335, content=<a href='/topic/show?id=1ae010211143' target=_blank style='color:#2F92EE;'>#髓性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102111, encryptionId=1ae010211143, topicName=髓性)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Apr 13 05:00:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77421, encodeId=71aee742155, content=学习了 长知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaEJJAFMgSjibMicGVUgkmDBw4svXiccQxZicwjRHNxGPTghAmITxP12Rcmm0yFKfwGwUaiaUwpPUUUTOd2g/0, createdBy=fcd21609070, createdName=hekzn, createdTime=Mon Apr 11 16:20:00 CST 2016, time=2016-04-11, status=1, ipAttribution=)]
    2016-04-14 李继凯

    值得学习

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1869334, encodeId=1a91186933410, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Mon May 02 04:00:00 CST 2016, time=2016-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85665, encodeId=af418566519, content=PDF文件:http://sci-hub.cc/10.1016/j.cell.2016.03.015, beContent=null, objectType=article, channel=null, level=null, likeNumber=205, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri May 13 17:57:00 CST 2016, time=2016-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85655, encodeId=9fec85655dc, content=请问 有人有PDF格式的吗 <br> , beContent=null, objectType=article, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/87BEB7C1C01469F4FC5BE4D730CCFC3E/100, createdBy=8ad91724127, createdName=sodabb8bb03c, createdTime=Fri May 13 15:23:00 CST 2016, time=2016-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1959591, encodeId=d12c195959159, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Fri May 06 04:00:00 CST 2016, time=2016-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78031, encodeId=fa5ce80310e, content=高大上的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:20:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78032, encodeId=8f50e803298, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:20:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77661, encodeId=6269e766118, content=夜间效果好吧?, beContent=null, objectType=article, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211004/21b1fa92cec74fb5b0b160bcc3a13716/3df82edb6cc74c2a9a5a9b5faef160f1.jpg, createdBy=40c81607191, createdName=shanganquan, createdTime=Wed Apr 13 13:16:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1424098, encodeId=5a8414240985f, content=<a href='/topic/show?id=4ece524e593' target=_blank style='color:#2F92EE;'>#急性骨髓性白血病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52475, encryptionId=4ece524e593, topicName=急性骨髓性白血病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07ce3903085, createdName=zxxiang, createdTime=Wed Apr 13 05:00:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1514393, encodeId=26d3151439335, content=<a href='/topic/show?id=1ae010211143' target=_blank style='color:#2F92EE;'>#髓性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102111, encryptionId=1ae010211143, topicName=髓性)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Apr 13 05:00:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77421, encodeId=71aee742155, content=学习了 长知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaEJJAFMgSjibMicGVUgkmDBw4svXiccQxZicwjRHNxGPTghAmITxP12Rcmm0yFKfwGwUaiaUwpPUUUTOd2g/0, createdBy=fcd21609070, createdName=hekzn, createdTime=Mon Apr 11 16:20:00 CST 2016, time=2016-04-11, status=1, ipAttribution=)]
    2016-04-13 shanganquan

    夜间效果好吧?

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1869334, encodeId=1a91186933410, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Mon May 02 04:00:00 CST 2016, time=2016-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85665, encodeId=af418566519, content=PDF文件:http://sci-hub.cc/10.1016/j.cell.2016.03.015, beContent=null, objectType=article, channel=null, level=null, likeNumber=205, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri May 13 17:57:00 CST 2016, time=2016-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85655, encodeId=9fec85655dc, content=请问 有人有PDF格式的吗 <br> , beContent=null, objectType=article, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/87BEB7C1C01469F4FC5BE4D730CCFC3E/100, createdBy=8ad91724127, createdName=sodabb8bb03c, createdTime=Fri May 13 15:23:00 CST 2016, time=2016-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1959591, encodeId=d12c195959159, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Fri May 06 04:00:00 CST 2016, time=2016-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78031, encodeId=fa5ce80310e, content=高大上的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:20:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78032, encodeId=8f50e803298, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:20:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77661, encodeId=6269e766118, content=夜间效果好吧?, beContent=null, objectType=article, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211004/21b1fa92cec74fb5b0b160bcc3a13716/3df82edb6cc74c2a9a5a9b5faef160f1.jpg, createdBy=40c81607191, createdName=shanganquan, createdTime=Wed Apr 13 13:16:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1424098, encodeId=5a8414240985f, content=<a href='/topic/show?id=4ece524e593' target=_blank style='color:#2F92EE;'>#急性骨髓性白血病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52475, encryptionId=4ece524e593, topicName=急性骨髓性白血病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07ce3903085, createdName=zxxiang, createdTime=Wed Apr 13 05:00:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1514393, encodeId=26d3151439335, content=<a href='/topic/show?id=1ae010211143' target=_blank style='color:#2F92EE;'>#髓性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102111, encryptionId=1ae010211143, topicName=髓性)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Apr 13 05:00:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77421, encodeId=71aee742155, content=学习了 长知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaEJJAFMgSjibMicGVUgkmDBw4svXiccQxZicwjRHNxGPTghAmITxP12Rcmm0yFKfwGwUaiaUwpPUUUTOd2g/0, createdBy=fcd21609070, createdName=hekzn, createdTime=Mon Apr 11 16:20:00 CST 2016, time=2016-04-11, status=1, ipAttribution=)]
  9. [GetPortalCommentsPageByObjectIdResponse(id=1869334, encodeId=1a91186933410, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Mon May 02 04:00:00 CST 2016, time=2016-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85665, encodeId=af418566519, content=PDF文件:http://sci-hub.cc/10.1016/j.cell.2016.03.015, beContent=null, objectType=article, channel=null, level=null, likeNumber=205, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri May 13 17:57:00 CST 2016, time=2016-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85655, encodeId=9fec85655dc, content=请问 有人有PDF格式的吗 <br> , beContent=null, objectType=article, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/87BEB7C1C01469F4FC5BE4D730CCFC3E/100, createdBy=8ad91724127, createdName=sodabb8bb03c, createdTime=Fri May 13 15:23:00 CST 2016, time=2016-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1959591, encodeId=d12c195959159, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Fri May 06 04:00:00 CST 2016, time=2016-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78031, encodeId=fa5ce80310e, content=高大上的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:20:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78032, encodeId=8f50e803298, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:20:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77661, encodeId=6269e766118, content=夜间效果好吧?, beContent=null, objectType=article, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211004/21b1fa92cec74fb5b0b160bcc3a13716/3df82edb6cc74c2a9a5a9b5faef160f1.jpg, createdBy=40c81607191, createdName=shanganquan, createdTime=Wed Apr 13 13:16:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1424098, encodeId=5a8414240985f, content=<a href='/topic/show?id=4ece524e593' target=_blank style='color:#2F92EE;'>#急性骨髓性白血病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52475, encryptionId=4ece524e593, topicName=急性骨髓性白血病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07ce3903085, createdName=zxxiang, createdTime=Wed Apr 13 05:00:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1514393, encodeId=26d3151439335, content=<a href='/topic/show?id=1ae010211143' target=_blank style='color:#2F92EE;'>#髓性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102111, encryptionId=1ae010211143, topicName=髓性)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Apr 13 05:00:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77421, encodeId=71aee742155, content=学习了 长知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaEJJAFMgSjibMicGVUgkmDBw4svXiccQxZicwjRHNxGPTghAmITxP12Rcmm0yFKfwGwUaiaUwpPUUUTOd2g/0, createdBy=fcd21609070, createdName=hekzn, createdTime=Mon Apr 11 16:20:00 CST 2016, time=2016-04-11, status=1, ipAttribution=)]
    2016-04-13 zhouqu_8
  10. [GetPortalCommentsPageByObjectIdResponse(id=1869334, encodeId=1a91186933410, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Mon May 02 04:00:00 CST 2016, time=2016-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85665, encodeId=af418566519, content=PDF文件:http://sci-hub.cc/10.1016/j.cell.2016.03.015, beContent=null, objectType=article, channel=null, level=null, likeNumber=205, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri May 13 17:57:00 CST 2016, time=2016-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85655, encodeId=9fec85655dc, content=请问 有人有PDF格式的吗 <br> , beContent=null, objectType=article, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/87BEB7C1C01469F4FC5BE4D730CCFC3E/100, createdBy=8ad91724127, createdName=sodabb8bb03c, createdTime=Fri May 13 15:23:00 CST 2016, time=2016-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1959591, encodeId=d12c195959159, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Fri May 06 04:00:00 CST 2016, time=2016-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78031, encodeId=fa5ce80310e, content=高大上的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:20:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78032, encodeId=8f50e803298, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:20:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77661, encodeId=6269e766118, content=夜间效果好吧?, beContent=null, objectType=article, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211004/21b1fa92cec74fb5b0b160bcc3a13716/3df82edb6cc74c2a9a5a9b5faef160f1.jpg, createdBy=40c81607191, createdName=shanganquan, createdTime=Wed Apr 13 13:16:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1424098, encodeId=5a8414240985f, content=<a href='/topic/show?id=4ece524e593' target=_blank style='color:#2F92EE;'>#急性骨髓性白血病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52475, encryptionId=4ece524e593, topicName=急性骨髓性白血病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07ce3903085, createdName=zxxiang, createdTime=Wed Apr 13 05:00:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1514393, encodeId=26d3151439335, content=<a href='/topic/show?id=1ae010211143' target=_blank style='color:#2F92EE;'>#髓性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102111, encryptionId=1ae010211143, topicName=髓性)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Apr 13 05:00:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77421, encodeId=71aee742155, content=学习了 长知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaEJJAFMgSjibMicGVUgkmDBw4svXiccQxZicwjRHNxGPTghAmITxP12Rcmm0yFKfwGwUaiaUwpPUUUTOd2g/0, createdBy=fcd21609070, createdName=hekzn, createdTime=Mon Apr 11 16:20:00 CST 2016, time=2016-04-11, status=1, ipAttribution=)]
    2016-04-11 hekzn

    学习了 长知识

    0

相关资讯

盘点:白血病新药研究进展汇总

白血病是一类造血干细胞恶性克隆性疾病。克隆性白血病细胞因为增殖失控、分化障碍、凋亡受阻等机制在骨髓和其他造血组织中大量增殖累积,并浸润其他组织和器官,同时正常造血受抑制。临床可见不同程度的贫血、出血、感染发热以及肝、脾、淋巴结肿大和骨骼疼痛,数据显示,我国各地区白血病的发病率在各种肿瘤中占第六位。 白血病的常见病因包括病毒、化学、放射以及遗传因素,个体的发病原因又因自身机体的条件及所处环

抗癌药物格列卫专利到期 患者使用伊马替尼5年可省10万美元

美国约翰霍普金斯大学的科学家们表示,抗癌药物格列卫(Gleevac)如果被伊马替尼(imatinib)取代,5年可为患者节省10万美元,可为拥有100位患者的保险公司节省900多万美元。 据合众社报道,随着诺华制药的专利药物格列卫专利期满,伊马替尼投放市场时,价格仅为格列卫的十分之一。 格列卫是一种酪氨酸激酶抑制剂,可用于治疗慢性骨髓性白血病,可以帮助5年内不复发的患者存活下去。在此期间,

抗击白血病,中医西医一起来

白血病是我们最熟知的血液病之一,而往往我们听到这个名字的时候,大多伴随着死亡,化疗,脱发等等情况。那么我们该如何面对这可怕的疾病?在临床中我发现应用中西医结合能够很好的控制这种恶性疾病。下面我们就来说说白血病该如何治疗。 急性白血病为恶性血液病,化疗是目前治疗本病的主要手段,但仍约有20%~50%的患者由于诱导期的骨髓抑制而死亡,或原发性耐药而不能取得完全缓解。而即便取得完全缓解的患者也可能会因

BiTE免疫疗法Blincyto治疗费城染色体阴性白血病III期临床成功

美国生物技术巨头安进(Amgen)近日公布了BiTE免疫疗法Blincyto(blinatumomab)一项III期TOWER研究的数据。该研究在费城染色体阴性(Ph-)复发性或难治性前体B喜报急性淋巴细胞白血病(ALL)成人患者中开展,调查了Blincyto相对于标准护理(SOC,4种)的疗效和安全性。一项既定的中期分析数据表明,Blincyto相比SOC显著延长了总生存期(OS),达到了研究的

NEJM:白血病患者福音,新的治疗目标或可改变生存

1月28日发表在《新英格兰医学杂志》上的文章公布了116名慢性淋巴细胞白血病(CLL)患者的试验结果,文章中写到:“新的治疗可以显著改善复发性CLL患者的预后,不过要完全缓解还存在困难。”该试验中的治疗药物是BCL2蛋白靶向药物 Venetoclax,BCL2蛋白倍认为是CLL细胞生存至关重要的物质。患者服用Venetoclax 150-1200mg/d,虽然试验中有89%的患者具有不良预后的临床

Am J Clin Nutr:ALL或AML儿童,超重/肥胖与更差的生存有关

研究者进行了一项荟萃分析,探究诊断小儿急性淋巴细胞白血病(ALL)或急性髓系白血病(AML)时更高的BMI,是否与更糟糕的无事件生存率(EFS)、总生存期(OS)和累积复发率(CIR)有关。研究者检索了相关数据库中关于小儿ALL或AML(0-21岁)、报道了BMI作为生存或复发的预测指标的研究。对更高的BMI(有肥胖(≥95%)或超重/肥胖(≥85%))与更低的BMI(非超重/肥胖(<85%))进

Baidu
map
Baidu
map
Baidu
map